Search

中文 / English

Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
 Copyright: Beijing Minhai Biological Technology Co., Ltd.    京ICP备10007676号-1   Powered by  www.300.cn Beijing    Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173           

Contact

Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Recruitment: 010-59613547
Marketing: 010-59613639
Medical support: 010-57864983

                             010-59613669

400 :4001899806

Links:

>
>
>
An authoritative interpretation of CCTV Finance Channel: The first "Vaccine Management Law" was introduced. What improvements will be made to domestic vaccines?

An authoritative interpretation of CCTV Finance Channel: The first "Vaccine Management Law" was introduced. What improvements will be made to domestic vaccines?

Release time:
2019/08/06
Page view

  Since the promulgation of the Vaccine Management Law, what impact will it have on the domestic vaccine industry? How do vaccine companies meet the management law? Recently, Kangtai Biological Dong Mi Miao Xiang and Quality Supervisor Zhu Zhengyu were interviewed by CCTV Financial Channel and introduced the company's active participation in the formulation of the law, as well as specific measures to continuously improve the quality control level and carry out innovative vaccine product development. The show aired at 14:00 on July 31.

 

 

https://mp.weixin.qq.com/s/-51NzRBQWkx2yGlrjhzIfQ